OPTH
Optimi Health Corp.
Price Chart
Latest Quote
$3.03
-0.09 (-2.88%)
Current Price
| Previous Close | $3.12 |
| Open | $3.10 |
| Day High | $3.16 |
| Day Low | $3.03 |
| Volume | 9,346 |
Stock Information
Note: Financial values converted from CAD to USD
| Shares Outstanding | 5.73M |
| Total Debt | $3.66M |
| Cash Equivalents | $9.30M |
| Revenue | $125K |
| Net Income | $-4.91M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $17.41M |
| EPS (TTM) | $-1.56 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $9.48M |
| Sales | $125K |
| Income | $-4.91M |
| Book/sh | $2.19 |
| Cash/sh | $2.28 |
Financial Ratios
| Quick Ratio | 1.62 |
| Current Ratio | 1.73 |
| Debt/Eq | 29.17 |
Returns & Margins
| ROA | -16.06% |
| ROE | -54.36% |
| Gross Margin | -175.41% |
| Operating Margin | -957.82% |
Ownership
| Insider Ownership | 12.66% |
| Institutional Ownership | 7.29% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 99.09 |
| P/B | 1.39 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $3.71 |
| SMA50 | $4.38 |
| RSI | 23.96 |
| ATR | 0.3243 |
| Shares Float | 4.65M |
| Short Ratio | 0.46 |
| Volatility | 1.57 |
| Rel Volume | 0.49 |
Performance History
| Week | -9.52% |
| Month | -37.32% |
| Quarter | -34.90% |
| YTD | -50.00% |
| 10 Years | -50.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $3.04 | 12,700 |
| 2026-10-26 | $3.12 | 11,300 |
| 2026-10-23 | $3.25 | 6,200 |
| 2026-10-22 | $3.28 | 20,500 |
| 2026-10-21 | $3.53 | 18,700 |
| 2026-10-20 | $3.36 | 18,400 |
| 2026-10-19 | $3.33 | 18,900 |
| 2026-10-16 | $3.38 | 19,900 |
| 2026-10-15 | $3.19 | 34,900 |
| 2026-10-14 | $3.17 | 54,600 |
| 2026-10-13 | $3.50 | 34,600 |
| 2026-10-12 | $3.63 | 54,200 |
| 2026-10-09 | $4.02 | 21,400 |
| 2026-10-08 | $4.09 | 16,300 |
| 2026-10-07 | $4.04 | 17,300 |
| 2026-10-06 | $4.13 | 52,400 |
| 2026-10-05 | $4.30 | 29,200 |
| 2026-10-02 | $4.49 | 13,900 |
| 2026-10-01 | $4.64 | 30,900 |
| 2026-09-30 | $4.71 | 34,800 |
| 2026-09-29 | $4.78 | 43,200 |
| 2026-09-28 | $4.85 | 15,800 |
About Optimi Health Corp.
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.
đ° Latest News
No news articles available at the moment. Check back later for updates on OPTH.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $350,598 | $84,340 | $-13,575 | $19,003 |
| Cost Of Revenue | $350,598 | $84,340 | $-13,575 | $19,003 |
| Total Revenue | $302,288 | $276,440 | $128,408 | $57,236 |
| Operating Revenue | $302,288 | $276,440 | $128,408 | $57,236 |
| Expenses | ||||
| Interest Expense | $377,011 | $304,442 | $30,992 | $19,850 |
| Total Expenses | $3,572,828 | $4,253,881 | $3,866,961 | $5,297,284 |
| Rent Expense Supplemental | $121,412 | $209,647 | $170,199 | $187,916 |
| Other Income Expense | $1,005,223 | - | $-10,605 | - |
| Net Non Operating Interest Income Expense | $-366,862 | $-302,552 | $65,735 | $27,619 |
| Interest Expense Non Operating | $377,011 | $304,442 | $30,992 | $19,850 |
| Operating Expense | $3,222,230 | $4,169,541 | $3,880,536 | $5,278,281 |
| Other Operating Expenses | $372,110 | $550,828 | $547,837 | $621,817 |
| Selling And Marketing Expense | $23,677 | $153,260 | $183,593 | $1,499,192 |
| General And Administrative Expense | $1,906,006 | $2,575,158 | $2,523,894 | $2,854,608 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-2,632,180 | $-4,279,992 | $-3,683,424 | $-5,212,429 |
| Net Interest Income | $-366,862 | $-302,552 | $65,735 | $27,619 |
| Interest Income | $10,149 | $1,890 | $96,728 | $47,469 |
| Normalized Income | $-3,637,402 | $-4,279,992 | $-3,672,818 | $-5,212,429 |
| Net Income From Continuing And Discontinued Operation | $-2,632,180 | $-4,279,992 | $-3,683,424 | $-5,212,429 |
| Net Income Common Stockholders | $-2,632,180 | $-4,279,992 | $-3,683,424 | $-5,212,429 |
| Net Income | $-2,632,180 | $-4,279,992 | $-3,683,424 | $-5,212,429 |
| Net Income Including Noncontrolling Interests | $-2,632,180 | $-4,279,992 | $-3,683,424 | $-5,212,429 |
| Net Income Continuous Operations | $-2,632,180 | $-4,279,992 | $-3,683,424 | $-5,212,429 |
| Pretax Income | $-2,632,180 | $-4,279,992 | $-3,683,424 | $-5,212,429 |
| Special Income Charges | $1,005,223 | $0 | $-10,605 | $0 |
| Interest Income Non Operating | $10,149 | $1,890 | $96,728 | $47,469 |
| Operating Income | $-3,270,540 | $-3,977,440 | $-3,738,554 | $-5,240,048 |
| Depreciation Amortization Depletion Income Statement | $673,886 | $615,456 | $517,327 | $208,188 |
| Depreciation And Amortization In Income Statement | $673,886 | $615,456 | $517,327 | $208,188 |
| Gross Profit | $-48,311 | $192,101 | $141,983 | $38,233 |
| Amortization Of Intangibles Income Statement | - | - | $517,327 | $208,188 |
| Depreciation Income Statement | - | - | $517,327 | $208,188 |
| Per Share | ||||
| Diluted EPS | $-0.85 | $-1.49 | $-1.28 | $-1.91 |
| Basic EPS | $-0.85 | $-1.49 | $-1.28 | $-1.91 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,586,505 | $-3,360,094 | $-3,124,499 | $-4,984,392 |
| Total Unusual Items | $1,005,223 | $0 | $-10,605 | $0 |
| Total Unusual Items Excluding Goodwill | $1,005,223 | $0 | $-10,605 | $0 |
| Reconciled Depreciation | $673,886 | $615,456 | $517,327 | $208,188 |
| EBITDA (Bullshit earnings) | $-1,581,282 | $-3,360,094 | $-3,135,105 | $-4,984,392 |
| EBIT | $-2,255,168 | $-3,975,551 | $-3,652,431 | $-5,192,580 |
| Diluted Average Shares | $2,268,737 | $2,116,389 | $2,055,971 | $1,842,220 |
| Basic Average Shares | $2,268,737 | $2,116,389 | $2,055,971 | $1,842,220 |
| Diluted NI Availto Com Stockholders | $-2,632,180 | $-4,279,992 | $-3,683,424 | $-5,212,429 |
| Other Special Charges | $-1,005,223 | - | - | - |
| Research And Development | $246,551 | $274,839 | $107,886 | $94,476 |
| Selling General And Administration | $1,929,683 | $2,728,419 | $2,707,487 | $4,353,801 |
| Other Gand A | $794,489 | $910,025 | $923,000 | $637,373 |
| Insurance And Claims | $182,504 | $230,717 | $248,199 | $344,721 |
| Rent And Landing Fees | $121,412 | $209,647 | $170,199 | $187,916 |
| Salaries And Wages | $807,602 | $1,224,769 | $1,182,495 | $1,684,599 |
| Gain On Sale Of Ppe | - | $0 | $-10,605 | $0 |
| Amortization | - | - | $517,327 | $208,188 |
Fetched: 2026-10-19
Balance Sheet (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $4,659,217 | $6,790,082 | $9,367,767 | $11,359,764 |
| Total Assets | $10,787,198 | $10,318,054 | $11,694,189 | $11,925,383 |
| Total Non Current Assets | $9,492,231 | $9,444,034 | $9,972,186 | $10,204,039 |
| Non Current Prepaid Assets | $12,443 | $12,443 | $11,282 | $7,562 |
| Non Current Deferred Assets | $572,903 | $0 | - | - |
| Current Assets | $1,294,967 | $874,020 | $1,722,003 | $1,721,345 |
| Prepaid Assets | $195,511 | $77,972 | $98,327 | $124,462 |
| Inventory | $220,094 | $634,512 | $552,579 | $187,714 |
| Receivables | $67,402 | $88,032 | $117,524 | $69,989 |
| Accounts Receivable | $67,402 | $88,032 | $117,524 | $69,989 |
| Cash Cash Equivalents And Short Term Investments | $811,959 | $73,505 | $953,574 | $1,339,180 |
| Cash And Cash Equivalents | $811,959 | $73,505 | $953,574 | $1,339,180 |
| Cash Equivalents | $3,545 | $67,364 | $67,364 | $1,058,644 |
| Cash Financial | $808,413 | $6,141 | $886,210 | $280,536 |
| Restricted Cash | - | - | - | - |
| Debt | ||||
| Net Debt | $3,679,798 | $1,854,168 | $207,745 | - |
| Total Debt | $4,622,527 | $1,950,917 | $1,210,590 | $111,737 |
| Long Term Debt And Capital Lease Obligation | $112,302 | $1,246,942 | $1,184,564 | $49,271 |
| Current Debt And Capital Lease Obligation | $4,510,225 | $703,975 | $26,027 | $62,466 |
| Current Debt | $4,491,757 | $680,730 | - | - |
| Other Current Borrowings | $4,491,757 | $680,730 | - | - |
| Long Term Debt | - | $1,246,942 | $1,161,319 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $6,127,980 | $3,527,973 | $2,326,422 | $565,620 |
| Total Non Current Liabilities Net Minority Interest | $112,302 | $1,246,942 | $1,184,564 | $49,271 |
| Current Liabilities | $6,015,678 | $2,281,030 | $1,141,858 | $516,348 |
| Current Deferred Liabilities | $147,321 | $82,532 | $79,773 | $0 |
| Payables And Accrued Expenses | $1,358,132 | $1,494,523 | $1,036,058 | $453,883 |
| Payables | $1,212,558 | $1,371,845 | $922,349 | - |
| Accounts Payable | $840,762 | $531,378 | $639,498 | - |
| Equity | ||||
| Common Stock Equity | $4,659,217 | $6,790,082 | $9,367,767 | $11,359,764 |
| Total Equity Gross Minority Interest | $4,659,217 | $6,790,082 | $9,367,767 | $11,359,764 |
| Stockholders Equity | $4,659,217 | $6,790,082 | $9,367,767 | $11,359,764 |
| Gains Losses Not Affecting Retained Earnings | $1,503,562 | $1,438,115 | $1,530,052 | $2,008,750 |
| Retained Earnings | $-19,316,916 | $-16,742,303 | $-12,511,979 | $-9,521,063 |
| Other | ||||
| Ordinary Shares Number | $76,139 | $2,237,508 | $2,057,281 | $1,913,204 |
| Share Issued | $76,139 | $2,237,508 | $2,057,281 | $1,913,204 |
| Tangible Book Value | $4,659,217 | $6,790,082 | $9,367,767 | $11,359,764 |
| Invested Capital | $9,150,974 | $8,717,754 | $10,529,086 | $11,359,764 |
| Working Capital | $-4,720,711 | $-1,407,010 | $580,145 | $1,204,996 |
| Capital Lease Obligations | $130,770 | $23,245 | $49,271 | $111,737 |
| Total Capitalization | $4,659,217 | $8,037,024 | $10,529,086 | $11,359,764 |
| Capital Stock | $22,472,572 | $22,094,269 | $20,349,694 | $18,872,077 |
| Common Stock | $22,472,572 | $22,094,269 | $20,349,694 | $18,872,077 |
| Long Term Capital Lease Obligation | $112,302 | $0 | $23,245 | $49,271 |
| Current Deferred Revenue | $147,321 | $82,532 | $79,773 | $0 |
| Current Capital Lease Obligation | $18,468 | $23,245 | $26,027 | $62,466 |
| Current Accrued Expenses | $145,574 | $122,678 | $113,710 | - |
| Dueto Related Parties Current | $371,797 | $840,467 | $282,851 | - |
| Net PPE | $8,906,885 | $9,431,591 | $9,960,904 | $10,196,476 |
| Accumulated Depreciation | $-1,957,053 | $-1,305,525 | $-696,700 | $-138,950 |
| Gross PPE | $10,863,938 | $10,737,115 | $10,657,604 | $10,335,426 |
| Other Properties | $1,255,010 | $1,240,740 | $1,140,906 | $808,143 |
| Machinery Furniture Equipment | $9,608,928 | $9,496,376 | $9,516,698 | $9,490,672 |
| Finished Goods | $220,094 | $608,962 | $509,811 | $139,246 |
| Raw Materials | $0 | $25,550 | $42,768 | $48,469 |
| Buildings And Improvements | - | $0 | $0 | $36,611 |
| Properties | - | $0 | $0 | $0 |
| Other Short Term Investments | - | - | - | $0 |
| Construction In Progress | - | - | - | - |
| Land And Improvements | - | - | - | - |
Fetched: 2026-10-19
Cash Flow Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-1,926,095 | $-3,144,180 | $-3,124,104 | $-8,318,261 |
| Operating Activities | ||||
| Operating Cash Flow | $-1,863,429 | $-3,036,124 | $-2,553,829 | $-3,247,326 |
| Cash Flow From Continuing Operating Activities | $-1,863,429 | $-3,036,124 | $-2,553,829 | $-3,247,326 |
| Operating Gains Losses | $-1,005,223 | - | $10,605 | - |
| Investing Activities | ||||
| Capital Expenditure | $-62,666 | $-108,056 | $-570,276 | $-5,070,935 |
| Investing Cash Flow | $-62,666 | $-109,218 | $-500,632 | $-2,234,559 |
| Cash Flow From Continuing Investing Activities | $-62,666 | $-109,218 | $-500,632 | $-2,234,559 |
| Capital Expenditure Reported | $-62,666 | $-108,056 | $-570,276 | $-5,070,935 |
| Net Other Investing Changes | - | $-1,161 | $59,007 | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $280,092 | $1,444,140 | $1,307,479 | $0 |
| Financing Cash Flow | $2,664,550 | $2,265,272 | $2,668,855 | $841,384 |
| Cash Flow From Continuing Financing Activities | $2,664,550 | $2,265,272 | $2,668,855 | $841,384 |
| Net Other Financing Charges | $-28,465 | - | - | - |
| Net Common Stock Issuance | $280,092 | $1,444,140 | $1,307,479 | $0 |
| Common Stock Issuance | $280,092 | $1,444,140 | $1,307,479 | $0 |
| Other | ||||
| Repayment Of Debt | $-33,452 | $-29,782 | $-56,812 | $-78,878 |
| Issuance Of Debt | $2,446,375 | $709,094 | $1,418,188 | $0 |
| Interest Paid Supplemental Data | $139,023 | $93,069 | $0 | - |
| End Cash Position | $811,959 | $73,505 | $953,574 | $1,339,180 |
| Beginning Cash Position | $73,505 | $953,574 | $1,339,180 | $5,979,680 |
| Changes In Cash | $738,454 | $-880,070 | $-385,605 | $-4,640,500 |
| Proceeds From Stock Option Exercised | $0 | $141,819 | $0 | $920,262 |
| Net Issuance Payments Of Debt | $2,412,923 | $679,312 | $1,361,376 | $-78,878 |
| Net Short Term Debt Issuance | $2,446,375 | $0 | - | - |
| Short Term Debt Issuance | $2,446,375 | $0 | - | - |
| Net Long Term Debt Issuance | $-33,452 | $679,312 | $1,361,376 | $-78,878 |
| Long Term Debt Payments | $-33,452 | $-29,782 | $-56,812 | $-78,878 |
| Long Term Debt Issuance | $0 | $709,094 | $1,418,188 | $0 |
| Change In Working Capital | $884,030 | $535,750 | $586,123 | $1,029,590 |
| Change In Other Working Capital | $64,789 | $2,759 | $79,773 | - |
| Change In Payables And Accrued Expense | $442,637 | $466,196 | $678,890 | $86,202 |
| Change In Payable | $442,637 | $466,196 | $678,890 | $86,202 |
| Change In Account Payable | $-32,534 | $-91,420 | $455,640 | $86,202 |
| Change In Prepaid Assets | $919 | $20,355 | $26,135 | $1,067,652 |
| Change In Inventory | $355,056 | $16,949 | $-151,141 | $-187,714 |
| Change In Receivables | $20,630 | $29,492 | $-47,535 | $63,450 |
| Changes In Account Receivables | $20,630 | $29,492 | $-47,535 | $63,450 |
| Other Non Cash Items | $183,139 | $50,061 | $-100,371 | $14,605 |
| Stock Based Compensation | $32,918 | $42,602 | $115,911 | $712,720 |
| Depreciation Amortization Depletion | $673,886 | $615,456 | $517,327 | $208,188 |
| Depreciation And Amortization | $673,886 | $615,456 | $517,327 | $208,188 |
| Net Income From Continuing Operations | $-2,632,180 | $-4,279,992 | $-3,683,424 | $-5,212,429 |
| Net PPE Purchase And Sale | - | $0 | $10,636 | $0 |
| Sale Of PPE | - | $0 | $10,636 | $0 |
| Gain Loss On Sale Of PPE | - | $0 | $10,605 | $0 |
| Net Investment Purchase And Sale | - | - | $0 | $2,836,377 |
| Sale Of Investment | - | - | $0 | $2,836,377 |
| Amortization Cash Flow | - | - | $517,327 | $208,188 |
| Amortization Of Intangibles | - | - | $517,327 | $208,188 |
| Purchase Of PPE | - | - | - | $-636,677 |
| Purchase Of Investment | - | - | - | - |
| Depreciation | - | - | - | - |
Fetched: 2026-10-19